Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Methyldopa MeSH Descriptor Data 2025


MeSH Heading
Methyldopa
Tree Number(s)
D02.092.311.200.538
D02.455.426.559.389.657.166.175.200.538
D12.125.072.050.685.400.600
D12.125.072.050.875.130.600
Unique ID
D008750
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D008750
Scope Note
An alpha-2 adrenergic agonist that has both central and peripheral nervous system effects. Its primary clinical use is as an antihypertensive agent.
Entry Term(s)
Aldomet
Alphamethyldopa
Apo-Methyldopa
Dopamet
Dopegit
Dopegyt
Dopergit
Hydopa
Meldopa
Methyldopate
Nu-Medopa
Sembrina
alpha-Methyl-L-Dopa
alpha-Methyldopa
Pharm Action
Antihypertensive Agents
Sympatholytics
Adrenergic alpha-2 Receptor Agonists
Registry Numbers
56LH93261Y
2579Z4P04J
0
Related Numbers
2579Z4P04J
555-30-6
CAS Type 1 Name
L-Tyrosine, 3-hydroxy-alpha-methyl-
NLM Classification #
QV 150
Public MeSH Note
65; ALPHAMETHYLDOPA was see METHYLDOPA 1977-94
Online Note
use METHYLDOPA to search ALPHAMETHYLDOPA 1977-94
History Note
65(63); ALPHAMETHYLDOPA was see METHYLDOPA 1977-94
Date Established
1965/01/01
Date of Entry
1999/01/01
Revision Date
2018/07/02
Methyldopa Preferred
Methyldopate Narrower
Aldomet Narrower
Dopegyt Narrower
Apo-Methyldopa Narrower
Dopamet Narrower
Hydopa Narrower
Meldopa Narrower
Nu-Medopa Narrower
Sembrina Narrower
page delivered in 0.134s